Genmab — Marts 2019

[E_L]

http://www.globenewswire.com/news-release/2019/03/22/1759230/0/en/Genmab-Announces-European-Regulatory-Submission-for-Daratumumab-in-Combination-with-Lenalidomide-and-Dexamethasone-in-Frontline-Multiple-Myeloma.html

[E_L]

Genmab Announces European Regulatory Submission for Daratumumab in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma

[Sukkeralf]

Nice

[E_L]

it remains strange to me that there is such a difference between US and european treatment regimen. I wonder if some day we'll see a head-to-head MAIA-Alcyone trial?

[peter12]

Now you can buy generic Revlimid in some european countries ?

[jkj]

Hvornår var det helt præcist at jannsen aflevere sidste data til fda ?

[jkj]

herfra skal vi vel regne med 4 uger ifølge rtor planen eller hvad ?

[jkj]

det var den 12 marts

[jkj]

tvivler på at de er hurtigere end skitseret, så i mellem 8 - 12 april

[jkj]

Men Seattle Genetics fik på under 14 dage efter sidst indlevering, så der er da en teoretisk risiko for cognac til kaffen i aften.

[Tandfeen-2]

Tror først det bliver efter påske

[Legolas23]

Darzalex har slået så mange rekorder, så mon ikke også godkendelsen kommer hurtigere end ventet.

[E_L]

Talking to The Pharma Letter, Janssen’s EMEA therapy area lead for hematology, Catherine Taylor, said: “I had commissioners coming up to me and telling me that “this is a game changer, this is going to change practice.” https://www.thepharmaletter.com/article/early-oncology-pacesetters-for-2019-will-seek-to-pick-up-where-janssen-left-on-in-2018

[lahn1]

Nice too

[polle1]

Flot dag i forhold til resten af markedet idag. God weekend

[Helge_LarsenPI-redaktør]

Just a moment...

(www.proinvestor.com)

[Helge_LarsenPI-redaktør]

God morgen.

[bibob]

God morgen.

[Tandfeen-2]

Det bliver ikke kønt mandag

[Helge_LarsenPI-redaktør]

Just a moment...

(www.proinvestor.com)